Nirmatrelvir + Ritonavir
Form: Tablet
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
Category: Anti Covid Medicines
Nirmatrelvir + Ritonavir, branded as Paxlovid®, is a leading oral antiviral approved in the US, EU, and globally for treating mild to moderate COVID-19 in high-risk adults. Paxlovid combines Nirmatrelvir 150 mg (2 tablets) with Ritonavir 100 mg (1 tablet), taken twice daily for 5 days. Available in convenient blister packs, it is in high demand for hospitals and COVID-19 programs. Through trusted PharmaB2B platforms, buyers can source Paxlovid or generic equivalents from verified manufacturers, ensuring regulatory compliance, competitive pricing, and global logistics. Partner with reliable suppliers for seamless bulk procurement and international distribution.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details Get Enquiry
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details Get Enquiry
Molnupiravir
Strength: 200 mg
Form: Oral capsule
Reference Brands: Lagevrio®(Us & EU)
View Details Get Enquiry
Favipiravir tablet
Strength: 200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View Details Get Enquiry